| http://purl.uniprot.org/citations/31284950 | http://www.w3.org/1999/02/22-rdf-syntax-ns#type | http://purl.uniprot.org/core/Journal_Citation |
| http://purl.uniprot.org/citations/31284950 | http://www.w3.org/2000/01/rdf-schema#comment | "Hyperglycemia-induced podocyte injury plays a vital role in the development of diabetic nephropathy. Sulfiredoxin-1 (Srxn1) is emerging as a cytoprotective protein that protects from various insults in a wide range of cell types. However, whether Srxn1 is involved in regulating hyperglycemia-induced podocyte injury and participates in diabetic nephropathy remains unknown. In the present study, we aimed to explore the potential role of Srxn1 in regulating high glucose (HG)-induced apoptosis and oxidative stress of podocytes in vitro. Results demonstrated that Srxn1 was induced in HG-stimulated podocytes. The depletion of Srxn1 by Srxn1 siRNA-mediated gene silencing significantly exacerbated HG-induced apoptosis and the production of reactive oxygen species (ROS), while Srxn1 overexpression attenuated HG-induced apoptosis and ROS production. In-depth molecular mechanism research revealed that Srxn1 overexpression promoted the nuclear expression of nuclear factor (erythroid-derived 2)-like 2 (Nrf2) and reinforced antioxidant response element (ARE)-mediated transcription activity. Moreover, results confirmed that Srxn1 increased the activation of Nrf2/ARE signaling associated with inactivating glycogen synthase kinase (GSK)-3β. Notably, the inhibition of GSK-3β significantly reversed Srxn1 silencing-induced adverse effects in HG-treated cells, while the knockdown of Nrf2 abrogated the Srxn1-mediated protective effect against HG-induced podocyte injury. Taken together, our results demonstrated that Srxn1 protects podocytes from HG-induced injury by promoting the activation of Nrf2/ARE signaling associated with inactivating GSK-3β, indicating a potential role of Srxn1 in diabetic nephropathy. Our study suggests that Srxn1 may serve as a potential target for kidney protection."xsd:string |
| http://purl.uniprot.org/citations/31284950 | http://purl.org/dc/terms/identifier | "doi:10.1016/j.bbrc.2019.06.157"xsd:string |
| http://purl.uniprot.org/citations/31284950 | http://purl.uniprot.org/core/author | "Chen S."xsd:string |
| http://purl.uniprot.org/citations/31284950 | http://purl.uniprot.org/core/author | "Shen Y."xsd:string |
| http://purl.uniprot.org/citations/31284950 | http://purl.uniprot.org/core/author | "Zhao Y."xsd:string |
| http://purl.uniprot.org/citations/31284950 | http://purl.uniprot.org/core/date | "2019"xsd:gYear |
| http://purl.uniprot.org/citations/31284950 | http://purl.uniprot.org/core/name | "Biochem Biophys Res Commun"xsd:string |
| http://purl.uniprot.org/citations/31284950 | http://purl.uniprot.org/core/pages | "1137-1144"xsd:string |
| http://purl.uniprot.org/citations/31284950 | http://purl.uniprot.org/core/title | "Sulfiredoxin-1 alleviates high glucose-induced podocyte injury though promoting Nrf2/ARE signaling via inactivation of GSK-3beta."xsd:string |
| http://purl.uniprot.org/citations/31284950 | http://purl.uniprot.org/core/volume | "516"xsd:string |
| http://purl.uniprot.org/citations/31284950 | http://www.w3.org/2004/02/skos/core#exactMatch | http://purl.uniprot.org/pubmed/31284950 |
| http://purl.uniprot.org/citations/31284950 | http://xmlns.com/foaf/0.1/primaryTopicOf | https://pubmed.ncbi.nlm.nih.gov/31284950 |
| http://purl.uniprot.org/uniprot/#_A2AQU8-mappedCitation-31284950 | http://www.w3.org/1999/02/22-rdf-syntax-ns#object | http://purl.uniprot.org/citations/31284950 |
| http://purl.uniprot.org/uniprot/#_A0A338P6P8-mappedCitation-31284950 | http://www.w3.org/1999/02/22-rdf-syntax-ns#object | http://purl.uniprot.org/citations/31284950 |
| http://purl.uniprot.org/uniprot/#_E9QAQ5-mappedCitation-31284950 | http://www.w3.org/1999/02/22-rdf-syntax-ns#object | http://purl.uniprot.org/citations/31284950 |
| http://purl.uniprot.org/uniprot/#_Q62368-mappedCitation-31284950 | http://www.w3.org/1999/02/22-rdf-syntax-ns#object | http://purl.uniprot.org/citations/31284950 |
| http://purl.uniprot.org/uniprot/#_Q3TTZ1-mappedCitation-31284950 | http://www.w3.org/1999/02/22-rdf-syntax-ns#object | http://purl.uniprot.org/citations/31284950 |
| http://purl.uniprot.org/uniprot/#_Q3TB31-mappedCitation-31284950 | http://www.w3.org/1999/02/22-rdf-syntax-ns#object | http://purl.uniprot.org/citations/31284950 |
| http://purl.uniprot.org/uniprot/#_Q5KU03-mappedCitation-31284950 | http://www.w3.org/1999/02/22-rdf-syntax-ns#object | http://purl.uniprot.org/citations/31284950 |
| http://purl.uniprot.org/uniprot/#_Q9D975-mappedCitation-31284950 | http://www.w3.org/1999/02/22-rdf-syntax-ns#object | http://purl.uniprot.org/citations/31284950 |
| http://purl.uniprot.org/uniprot/#_Q9WV60-mappedCitation-31284950 | http://www.w3.org/1999/02/22-rdf-syntax-ns#object | http://purl.uniprot.org/citations/31284950 |
| http://purl.uniprot.org/uniprot/A2AQU8 | http://purl.uniprot.org/core/mappedCitation | http://purl.uniprot.org/citations/31284950 |
| http://purl.uniprot.org/uniprot/Q3TTZ1 | http://purl.uniprot.org/core/mappedCitation | http://purl.uniprot.org/citations/31284950 |
| http://purl.uniprot.org/uniprot/Q62368 | http://purl.uniprot.org/core/mappedCitation | http://purl.uniprot.org/citations/31284950 |